Insulin-like growth factor-binding protein-3 is induced by tamoxifen and fulvestrant and modulates fulvestrant response in breast cancer cells
IntroductionInsulin-like growth factor binding protein-3 (IGFBP-3) exerts varying effects on estrogen receptor alpha (ERα)-positive and triple-negative breast cancer (TNBC) cells. In ERα-positive cells, IGFBP-3 is antiproliferative and proapoptotic. In contrast, IGFBP-3 stimulates proliferation in t...
Saved in:
| Main Authors: | Keenan L. Flynn, Yan Zheng, Janel Y. Sowers, Nefretiri J. T. Masangya, Kevin D. Houston |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-11-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1452981/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
“Four years of remission with fulvestrant monotherapy in advanced endometrioid adenocarcinoma of the endometrium Harboring an ESR1 Mutation: A case Report”
by: João Felipe Feldmann, et al.
Published: (2025-06-01) -
Dynamic methylation and expression of alternative promoters for oestrogen receptor alpha in cell line models of fulvestrant resistance
by: Juliane Albrecht, et al.
Published: (2025-01-01) -
Insulin-like Growth Factor-Binding Protein-1 (IGFBP-1) as a Biomarker of Cardiovascular Disease
by: Moira S. Lewitt, et al.
Published: (2024-11-01) -
Adding capivasertib to fulvestrant in patients with hormone receptor-positive advanced breast cancer: a cost-effectiveness analysis
by: Yitian Lang, et al.
Published: (2025-01-01) -
Posttranslational modifications of YAP/TAZ: molecular mechanisms and therapeutic opportunities
by: Zhenxiong Zhang, et al.
Published: (2025-07-01)